The Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder(III): Pharmacologic Treatment.
- Author:
Hee Jeong YOO
1
;
Su Jin YANG
;
Dongwon SHIN
;
Hwayeon KANG
;
Bung Nyun KIM
;
Ji Hoon KIM
;
Donghyun AHN
;
Hanik K YOO
;
Keun Ah CHEON
;
Hyunju HONG
Author Information
1. Department of Psychiatry, Seoul National University Bundang Hospita, Seoul, Korea.
- Publication Type:Controlled Clinical Trial ; Practice Guideline ; Review ; Clinical Trial
- Keywords:
ADHD;
Pharmacological Treatment;
Practice Parameter
- MeSH:
Adrenergic alpha-Agonists;
Advisory Committees;
Antidepressive Agents, Tricyclic;
Bupropion;
Europe;
Korea;
United States;
Atomoxetine Hydrochloride
- From:Journal of the Korean Academy of Child and Adolescent Psychiatry
2007;18(1):16-25
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The objective of this review is to propose the Korean practice guideline for pharmacological treatment of attentiondeficit hyperactivity disorder(ADHD). For making the guideline, the authors used the evidence-base approaches derived from a detailed review of literature including wide range of controlled clinical trials, studies of side effects of drugs, toxicological reports, and meta-analyses published in United States and Europe, as well as inside Korea. The review committee composed of experts in ADHD in Korea has reviewed the parameter. The practice parameter for pharmacological treatment describes the use of stimulants, atomoxetine, modafinil, bupropion, tricyclic antidepressants, and alpha-adrenergic agonists and their side effects. The recommendations of pharmacological treatment are proposed at the end of the article.
